Clinical Trial 12585

Towson, MD 21204


Study Summary:

A phase III, multinational, randomized, double-blind, placebo-controlled, parallel-group study to investigate the clinical efficacy and safety of DIAPEP277 in newly diagnosed type 1 diabetes subjects.


Qualified Participants Must:

• Be 20-45 years of age
• Be diagnosed with type 1 diabetes for up to 5 months


Qualified Participants May Receive:

Eligible participants will receive up to $325 for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.